T‐Cell Receptor Repertoires Show Dynamic Variation Between Diagnosis and Relapse of Diffuse Large B‐Cell Lymphoma - Wight - 2025 - eJHaem - Wiley Online Library onlinelibrary.wiley.com/doi/10.1002/...

NEW in @natmed.nature.com: a study led by MSK and the Icahn School of Medicine at Mount Sinai suggests that #AI could significantly improve how tumor samples are analyzed in the lab using a model trained to identify #LungCancer mutations.

Thank you to Blood Cancers Today for allowing me to talk about our newly published study in @BloodAdvances on the increased risk of #ALCL Breast Implant associated lymphoma in #BRCA 1/2 carriers. #MSKCancerCenter #ColumbiaMSPH. www.bloodcancerstoday.com/post/brca-mu...

"T-Cell Redirecting Strategies in Large B-Cell Lymphoma and Follicular Lymphoma" by Gloria Iacoboni @icmlugano.bsky.social onlinelibrary.wiley.com/doi/abs/10.1...

Patel: JNJ4496 (anti CD19/20 tandem CAR) RR DLBCL, 41BB costim • global Ph 1B • med age 72y • at RP2D, ORR 100%, CRR 80% • no G3+ CRS, 8% ICANs Very impressive results #18ICML #ICML25 #lymsm

The results showing the benefit of combining the non-ATP competitive Pi3Kδ inhibitor roginolisib with venetoclax in lymphoid tumors are out in Haematologica. A collaboration of @iorbellinzona.bsky.social, Jennifer Brown’s group and iOnctura colleagues. haematologica.org/newsletter/v...

🧵5 Top Free Alternatives to BioRender for Scientific Illustrations! These five websites offer free scientific illustrations for biologists. Great for presentations, research papers and other research communication needs. Save and share the post!

Don't miss the last webinar of this series next week with Connie Batlevi & Jamie Hirata presenting on Careers in Pharma along with Casulo Carla & @judithtrotman.bsky.social ! Register at us06web.zoom.us/webinar/regi...

MedNews Week x OncLive Present: 🌟 Voices in Lymphoma: Women Shaping Care 🌟 Join Dr. Catherine Thieblemont (Hospital Saint-Louis) and Dr. Paola Ghione (MSKCC) for an in-depth conversation on Marginal Zone Lymphomas—highlighting evolving treatment landscapes, current challenges & what lies ahead.

Join us tomorrow for last webinar of this series "Careers in Pharma" with Dr Connie Batlevi & Jamie Hirata along with Casulo Carla & Judith Trotman Register at us06web.zoom.us/webinar/regi...

New evidence @nejm.org today that age-related clonal hematopoiesis (CHIP) has a driver role in evolution of solid cancers www.nejm.org/doi/full/10.... www.nejm.org/doi/full/10....

🎉 A new record at #18ICML : more than 1000 abstracts - a big thank you to all authors! The scientific programme will be released on 30 April! 📣 We strongly recommend virtual registration (for the on-site one, a waiting list available): shorturl.at/JefAU ▶ Watch our video to discover exciting news!

Hello Bluesky community! We are excited to join you here - this is the official account of the International Conference on Malignant Lymphoma (ICML). Looking forward to seeing you in Lugano on June 17-21! www.icml.ch www.icml.ch/icml/congres... #18ICML

the preprint of our work showing that the anti-metabolite KAT/3BP has in vitro and in vivo anti-tumor activity in #lymphoma models is out in bioRxiv. @iorbellinzona.bsky.social @usi.ch @snf-fns-ch.bsky.social

High-grade B-cell lymphoma shows a lower CNS relapse risk than expected, with distinct patterns in gene expression subgroups. by Alduaij W, Jiang A (...) Savage KJ et 15 al. in Blood #MedSky 📖 read the article:

Our #lymsm patients are exposed to significant doses of steroids & chemo that reduces bone density. Congrats to my colleague Dr Douglas for leading our study in #Haematologica that shows we can identify those at risk on the CT component of their staging PET/CT & intervene doi.org/10.3324/haem...

Poster #ASH24: 50% of pts with NHL have financial toxicity! In MV model, FT strongly associated with younger age at diagnosis, income, employment and getting systemic chemo. #lymsm #MajorPROsASH

Neelapu: long term Zuma5 FU (Axi-cel FL) - 127 efficacy pts, R/R FL 2+ prior lines - at >5y FU, >50% alive, no further Rx - PFS at 5y approx 50% - NRM approx 15% - only 1 PD event after 4y - Apply to high risk incl POD24 Does support curative potential in FL #ASH24 #lymsm

Love seeing the Nivo-AVD story in older patients grow in Frontline c Hodgkin Lymphoma | Journal of Clinical Oncology ascopubs.org/doi/10.1200/... congrats @PallawiTorkaMD Need effective tools is frail/unfit/super elderly #lymsm

#bluetoirial courtesy of @mskcancercenter.bsky.social Roni Shouval Now out in #BloodCancerDiscovery Comprehensive study (n=263) on immune reconstitution after CD19 #CARTcells (axi/liso/tisa-cel) in LBCL. Led by the talented @DannyLuan6 #Lymphoma #NKcells #lymsm 1/6 aacrjournals.org/bloodcancerd...

NIH appears to have canceled/postponed all of its study sections—the independent review panels that approve federal grants for health research. Such grants fund the work/salaries of 300k people at more than 2,500 institutions

This is where you’ll find me for the next couple of weeks ;)

PSA: Don’t take your iron supplement with milk, tea or coffee! These all inhibit absorption.

The data on #microbiome and #immunotherapy continues to accumulate #oncsky #cansky #medsky bit.ly/3VAcdOC

Plasma proteins and brain aging. Assessment of ~3,000 proteins in ~11, 000 UK biobank participants w/ over 11,000 MRI phenotypes 1. Brain aging is non-linear, with protein waves at ages 57, 70 and 78

Telehealth Will Die In 3 Weeks Without Congressional Action www.forbes.com/sites/judyst...

How to Write Your First Research Paper Open Access pmc.ncbi.nlm.nih.gov/articles/PMC...

Such a beautiful energy @womeninlymphoma.bsky.social @judithtrotman.bsky.social and plans for the next WiL projects #lymsm #ASH24

Excellent data with PEMBRO-GVD in relapsed #Hodgkin lymphoma in study by @mskcancercenter.bsky.social Alison Moskowitz - she will present additional data tomorrow #ash24 #lymsm

Dubois: senior IPI - LYSA study developing prognostic score for 80y+ treated with immunochemo - years over 80, no. aaIPI score, albumin < 35, IPI > 3x ULN - clear impact in mean restrict survival time - outperforms existing prog scores. #ASH24 #lymsm

From #ASH24 oral: CTCL global QOL scores & pruritis improve in both responders & non-responders (non-responders just have a delayed improvement). No pts with Sezary had severe CTCL symptoms by week 81! PRO benefit in both SS & MF. #lymsm #MajorPROsASH

Dreyling: longer FU of Triangle (55mo) - Signif OS benefit of Ibr containing arms - FFS: ASCT+ibr superior to ASCT - FFS: Ibr looks superior to ASCT - ASCT maybe important for high Ki67 / blastoid / p53 abn - ASCT comes at a tox cost With an OS survival, imperative BTKi comes to 1L #ASH24 #lymsm

My ex-fellow and now colleague Dr Kat Lewis in action presenting the ALLG PACIFIC study of pembrolizumab R-CHOP in primary mediastinal B-cell lymphoma. Stop by poster 1721! #ASH24 #lymSM

Upfront geri assessment in NHL #ASH24 - poor correlation between CGA and clinician-assessed ECOG/CARG (not surprising) - frail = most non-heme AEs (infx, cardiac tox) - fit/prefrail good OS; frail very poor OS We need to stop relying on ECOG for dose/tx optimization. #lymsm